It's been characterized variously as sinister, evil and a corporate bully. Surveys rank it among the most hated companies in America. And now Bayer AG wants to buy it.
The deal proposed by Bayer on Wednesday has an undeniable industrial logic, marrying its crop-chemicals operations with Monsanto Co.'s market-leading seed business to create the largest company of its kind. But if the takeover succeeds, Bayer will likely find itself in the crosshairs of Monsanto's army of critics.
In the two decades that St. Louis-based Monsanto has sold genetically modified crops, it has become a lightning rod for environmental activists warning of the dangers of cultivating and consuming genetically modified organisms. It's been attacked for the legal tactics used to enforce its patents, accused of being a factor in farmer suicides in India, and blamed for contributing to the decline of the monarch butterfly. And while Monsanto has rejected criticism in each case, the controversies have indelibly marked its image.
Monsanto's "reputation is disastrous, it's a mess," said Eric Schiffer, chief executive officer of Irvine, Calif.-based Reputation Managements Consultants.com, an advisory firm. "Monsanto is viewed as evil."
In Harris Poll's 2015 study of America's most loved and hated companies, Monsanto garnered a "poor" rating and ranked fourth-lowest -- not as bad as bottom-of-the-table Goldman Sachs Group Inc., but nevertheless lagging behind companies including BP Plc and Halliburton Co., both of which were involved in the Deepwater Horizon oil spill.
Today, activists in locations around the world will participate in the March Against Monsanto, according to the organizers, who are calling for further research on the health effects of genetically modified organisms -- there's also a counterdemonstration the same day.
Monsanto has manufactured controversial compounds throughout its history, including highly toxic polychlorinated biphenyls, also known as PCBs. It was also among companies that made the mixture of herbicides known as Agent Orange and used as a defoliant by the U.S. in the Vietnam War.
In the event of a deal, Bayer would probably drop the Monsanto name and conduct a review of its business practices, including how to litigate on patents, Schiffer said. Such moves might encourage investment from money managers who until now "didn't want to be aligned with evil," he said. Bayer wouldn't comment on Monsanto's reputation.
Monsanto has worked hard to be part of debates surrounding food and agriculture and has invested to provide the public with information about the company and its role in the food chain, spokesman Sara Miller said Thursday in an emailed statement.
The company's approach was different 20 years ago, when genetic engineering technology was introduced. At the time, Monsanto dealt with public concerns with "hubris and naivety," Chief Executive Officer Hugh Grant said in a March interview with The Independent. Being the market leader and inventor of some genetic engineering technologies has made the company "the de facto spear catcher" for those concerns, he told NPR in an interview the same month.
Monsanto isn't the only producer of modified seeds. Bayer makes them, and that doesn't appear to have hurt public perceptions, said Jonas Oxgaard, an analyst with Sanford C. Bernstein & Co. in New York who has an "underperform" rating on the shares.
Monsanto attracts more scrutiny on social media platforms than its peers and doesn't have a clear, upbeat message that informs the public about the positive things the company is doing, said John Kriney, the founder of marketing company OptFirst in Miami Shores, Fla. Monsanto's public-relations strategy appears to react to every itemized attack on its operations, which leaves the company in a negative cycle, he said.
"It's almost a buzzword for attracting attention right now, Monsanto's name," Kriney said in a telephone interview. "I just don't think that's a winning battle."
Companies like Monsanto can avoid being the "lowest hanging fruit" for the environmental lobby and other public-policy groups by more clearly defining their focus and investing to create a more positive narrative, said Jim Courtovich, managing partner of Sphere Consulting in Washington. Bayer has a great reputation in communicating and can help better educate people on Monsanto's business, he said.
"Monsanto has been better defined by the critics than they should've been," Courtovich said in a telephone interview. "We see often times a company has a terrible reputation that often is not that they've done something horrendously bad. They've just let others define them."
Business on 05/21/2016